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Abstract
Objective: The purpose of this research is to
analyzethe difference between the mean serum levels
of endostatinin early onset preeclampsia (EOPE), late
onset preeclampsia (LOPE) and normal pregnancy.
Method:This research design was an
analytic cross-sec{ional observation on 80 pregnant
women with EOPE, LOPE and normal pregnancy with
matched gestational age in M. Djamil hospital,
Reksodiwiryo hospital, Bhayangkara hospital, Rasidin
Padang hospital, and Anak Air of Public Service,
fromJuly to November 2015. Samples were selected
based on consecutive sampling. Blood was collec{ed
intravenously, centrifuged and endostatinserum
measured by ELISA method in the Laboratory of
Biomedical Faculty of Medicine Andalas University.
Normality test data with Shapiro-Wilk, unpaired t-test
independent for mean difference, using SPSS.
Result: The mean levels of endostatinin the
EOPE group and normal pregnancy group is 125149.3
ng/ml and 90.8*28.3n9/ml (p<0.05), in the LOPE
group and normal pregnancy group is 86.2t21.8 ng/ml
and 78.3119.5 ng/ml (p>0.05) and finally in the EOPE
group and LOPE group is 125t49.3n9/mland
86.2121 .8 ng/ml (p<0. 05).
Conclusion:The mean levels of endostatinin
the PE group is higher than normal pregnancy.
The mean levels of endostatinin the EOPE group is
higher than LOPE group.
This Paper will also be published in
lndonesian in The JumalKesehatanAndalas. 2016Key words:endostatin, early onset severe
preeclampsia, late onset severe preeclampsia
Abstrak
Tujuan:Tujuan
pe neliti ani n i ad a I a h me n g a n a I i s i s kad a rc nd o stati n a nta rupreeklamsiawitandini (PEAD),
preeklamsiawitanlambat (PEAL) danhamil normal.
Metode: Desainpenelitianadalahcrcss
sectionafterhadap 80 ibuhamil (PEAD, PEAL
sertahamil normal
denganusiakehamilansamadengankelompok PE-
normal untukkalompok PEAD dan normal
untukkelompok PEAL) di RSUPdr. M, Diamit, RS.
Tingkat llldr. Reksodiwiryo, RS. Bhayangkan, RSUD.
Dr.Rasidin, danPuskesmasAnak Air Padang, Juli-
November 2A15. Sampelbedasarkanconsecutive
sampling. funh intavenasampel, disentrifuge,
didapatkan serum dan diukur dengan metode ELISA
di LabontoiumBiomedik FK- UNAND. Uiinormalitas
data dengan Shapiro Wlk, bedarentadenganuii t
tida kbe rpa sa nga n, da ndiolahmengg u nakan SPSS.Hasil: Rentakadarendostatinkelompok
PEAD denganhamil normal adalah 125149,3 ng/ml
dan 90,8*28,3n91m1 (p<0,05), kelompok PEAL
denganhamil normal adalah 86,2fl1,8 ng/ml dan
7 8,3!1 9,5 ng/ml (p> 0, 0 5) d a n kel om po k P EA D de ng a n
PEAL adalah 125x49,3 ng/mldan 86,2t21,8n9/ml
(p<0,05).
Kesimpulan: Renta kadar endostatin PE
lebih tinggi dari pada hamil normal. Rerata kadar
endostatin PEAD lebihlinggi dar ipada PEAL.
Penelitian ini juga akan dipublikasikan di
Jumal Kesehatan Universitas Andalas. 2016
Kata kunci: Endostatin, Preeklams iAwitan
Dini, Preeklamsi Awitan Lambat
Correspondenee: Yusrawati. Department Of Obstetrics and Gynecology, Dr. M. Djamil Hospital. Jl.
PerintisKemerdekaan, Padang. Telephone : O811ffi8272, Email: vusrawati 65@vahoo.co.id.
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INTRODUCTION
Preeclampsia (PE) is one of the major
problems in pregnancy that can cause maternal
mortality being a factor in 10-15% of all maternal
deaths worldwide.lThe frequency of this
condition varies from country to country.2
5-8% of pregnancies in USA are
affected by this condition and it was the cause of
2oo/o ol the maternal deaths in Canada in 1999-
2000.3 High blood pressure caused 30% of all
maternal deaths in lndonesia in 2010, and 3 -
10% of these involved preeclamsia.4 About 45olo
of maternal deaths in West Sumatera are related
to high blood pressure, preeclampsia and
eclampsia. According to figures from Dr. M
Djamil hospital preeclampsia is an increasing
problem with 5.5% in 1998-2002,58.3o/o in 2011,
11.5o/o in 2012 and 12.o/o in 2013.6
Preeclampsia can cause two different
conditions depending on the stage of pregnancy.
In the first 34 weeks of pregnancy EOPE is
related to failure of trophoblast invasion and
remodelling of spiral arteries in the uterus. LOPE
after the 34 week mark, is caused by an
increase in maternal blood vessel inflammation
in a previously normal pregnancy or atherosis of
a placenta that less elastic was previously
ndeveloping normally.
The pathogenesis of PE begins when
the angiogenic and antiangiogenic factors in the
placenta are out of balance.T'8One
antiangiogenic factor, endostatin, is a product of
collagen XVlll with a C terminal and a
-'-*
molecular weight of 20 kDa. lt causes
endothelial cell apoptosis,s inhibits cell
proliferation and migration. ln some studies, the
level of endostatin has been observed to be
elevated in women with severe preeclampsia.e'10
Other studies report no increase in levels in
normal pregnancy indicating that the placenta is
not contributing to serum concentration of
endostatin. No clinically significant difference
has been observed between preoxidised lipid
levels in PE or normal pregnancy.'1 As a result
of this controversy it was decided to conduct this
study to establish the difference in mean levels
of endostatin between EOPE and normal
pregnancy, LOPE and normal pregnancy and
between EOPE and LOPE.
METHOD
This study design was an analytic cross-
sectionalobservation in dr. M. Djamil hospital, dr.
Reksodiwiryo hospital, Bhayangkara hospital, dr.
Rasidin Padang hospital, and Anak Air
ofcommunity health clinic, from July to
November 201 5. Ethical approval no. PE.27 .2O1 5
for the research was obtained from the ethical
committee for research at dr. M. Djamil
hospital.12The population studied was all women
who were 20 weeks or more pregnant who were
treated as outpatients or admitted to delivery
wards in the these hospitals whether they had a
normal pregnancy, EOPE or LOPE. Each PE
sample was matched with a sample with normal
pregnancy and similar gestational age.
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Three ml blood samples were taken
from the antecubital area by the technician in the
delivery ward or midwifery clinic. These samples
were placed in a vacutainer containing 2.5 ml
ethylenediaminetetraacetic acid (EDTA) and
centrafuged at 2000-3000 rpm. The serum was
stored at -ao 0C in the Andalas University
Biomedic laboratory in Padang. A 0,5m1 sampel
of the blood was placed in another
vacutainerwithout EDTA for Hb and Leukocyte
levels at the blood testing clinic.
Endostatin levels were measured using
a Ray Bio Tech ELISA kit in the Andalas
University Biomedic laboratory. Data obtained
was analysed using the unpaired t test.
RESULT
Tablel. Characteristics of the women in the <34
week gestation age sample
\-
1. Distribution of for Each
Graphic 2. Distribution of History of Prceclampsia
for Each
Graphic 3. Distribution of History of Hypertension
for Each
Graphic 4. Distribution of History ofDiabetes
Mellitus for Each
Table3. Aver:age Level of Endostatin for Each
Group
Characteristic EOPE(MeanlSD)
Normal
(Mean:SD) P
Age (years)
BMI before
32.5rr.O
23.5r1 .8
1t.3rl .5
13373.6a
4829_8
30.014.1
22.8!2"1
10.8t0.9
8105.0+
1451.5
0,179
0,246
4,220
0,000
pregnancy
(ks/m')
Hb levels
(gldl)
Leukocyte
count (m")
Table 2. Characteristics of the women in the >34
week gestation age sample
LOPE Normal
Characteri -- Me 
- 
Mesrc t3il [Hl; !3il [Hl; P
Age 31 .2*(years) 7.3
BMIbefore 25.3 j
pregnancy
(kg/m')
2.3
Hb levels
(sr/dl)
1't .5+
1.6
Leukocyte
count (m3)
30.01
5.4
23.1 t
2.9
't0.6!
1.1
0,559
0,012
0,655
1 3305
(8400-
24
8325
(s400-
9900)
{.fi{
EOPE normal LOPE normal
r Nulliparity r Multiparity
8s%800/,
4s,Es%I
100%
50%
0o/o
150%
700%
5OYo
lYo
t00o/o tOA% 95% L00%
EOPE Norrnal 1 LOPE Normal2
s%0o/o
r positif r negatif
t5Ao/o
LOO%
so%
0%
gS% 100% 95% t00Yo
EOPE Normal LOPE Normal
r positif r negatif
5% 5o/o0% 0o/o
150%
too%
5A%
o%
91o/o 1A0o/o gS% t00%
EOPE Normal LOPE Normal
r positif r negatif
0o/o
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EOPE
Normal
>34 weeks
LOPE
Normal
Severe PE
EOPE
LOPE
Gestational Endostatin Levels (ng/mL) P
Age Mean SD
<34 weeks
\*
Endostatin is bound to several membrane
protiens such as integrin o5B1, integrin ovB3,17
inhibiting the activation of cellular signaling
com ponents incl uding FAK danexfia ce ll u I a r reg u I ated
krnase(ERK). Endostatin depressesinsu/rn grcwth
factor)l (lcF-ll)- induces FAK
Phosphorylation,/protein kinase B/mamalian target of
rapamycin (mTOR), PT0S6Kinase (S6K) and activation
of ERt<1t2.15'17
Endostatin inhibits FGF and VEGF, migration of
human microvascular endothelial cells and influences
the formation of blood vessels in the
embryo.lSEndostatin is also known to control
migrasion and proliferation of cells like phospholipase
C-y (PLC-y), PKB, p44142, mitogen ac:tivated protein
kinase (MAPK), p38 MAPK and p2l-adivated kinase
(PAK) via the intracellular pathway.
One EOPE patient had the highest endostatin
level (200,02n9/ml) measured. On average this group
were nulliparous with gestation age was 2$30 weeks,
had Hb levels of 15,3 gr/dl, a leukocyte count of
21800 m3, blood pressure 17U13O mmHg and
proteinuria +2.
One mechanism that may influence the increase
in high endoslatinlevels in this group is immune
maladaptation. ln nulliparous EOPE mothers, there is
inadequate produclion of blocking antibodies for the
trophoblast to be protecled. Furthermore there is a
reduction in the expression of Human Leucocyte
Antigen-G (HLA-G) in the cytotrophoblast resulting in
a reduction in the protection of the trophoblast from
destruc{ion from natural killer (NK) and cytotoxic
cytokines interleukin- 2 (lL-z) inhibiting the trophoblast
invasion of the spiral arteries. For nulliparous
particularly, conception that happens too quickly after
the exposure lo sperm does not allow sufficient
timefor the mother to produce btocking antibodies.l9
High matemal Hb levels will influence
invivovascular resistance, Hb in red blood cells can
125.1
90.8
86.2
78.3
125.1
86.2
49.3
28.3
0,011*
0,237
0,003*
21.8
19.5
49.3
21.8
(* difference is statistically significant)
DISCUSSION
Difference in average Endostatin levels between
EOPE and normal pregnancy
The average level of endostatin amongst EOPE
subjects was 125.1 ng/ml compared to 90.8n9/ml for
women with normal pregnancy. This difference of 34.3
ng/ml with a 95o/o confidence interval of 8.4-60.3n9/ml
and p=0.011 is statistically significant (at the 95026
level).
There is a significant increase in endostatin
concentrations in PE patients compared with those
with normal pregnancies from early pregnanry,13 and
a high level of endostatin at gestation age 16-20
weeks indicates a higher risk of developing ef .14
During pregnanry, extravilloustrophoblast (EW)
establishes uteroplacentalcirculation by invading the
decidua and spiral arteriesl5 beginning with the
process of differentiation of the villi in the placenta,
proliferation of cells invading the extracellular matrix
(ECM), requiring a focal adhesion that is mediated by
tyrosine kinase that is the focal adhesion kinase
(FAK).16
The invasion of EW is controlled by stimulation
from pro danantimigration, tumor grcwth factor-B 1-3
ffGFF 1 -3),tissue inhibitor netalloprcteinase C[IMP),
and plasminogen activator inhibitor (PAl-7 and 2). lf an
imbalance occurs between factors and the ECM like
endostatin, it will contribute to a pathological
disturbance of pregnancy such as preeclampsia.l5
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inhibit endothelium dependent vasodilatation so that
an increase in hemoglobin concentration of 1 gm/dl
can reduce the produc;tion of Nitric Oxrde (NO).
It is known that NO plays a role in the migration
of endotel cells induces VascularEndothetial Grcwth
Factor\VEGF) importanl in increasing proliferation,
migrasion and survival of endotel cells along with
increasing the permeability of the capillaries. As
embrio cells need oxygen as a source of energy for
molecular processes, VEGF has an important role in
the vasculogenesis and angiogenesis of the embryo.
Damage to a single VEGF allele will result in abnormal
blood vessels including those in the placenta resulting
in embryo death at 10 to 12 days. 20
Endostatininterfers with the bonding process
between VEGF and Kinase insert domain receptor
(KDRyFlk 1/VEGFR2). KDR/Flk1A/EGFR2 is a VEGF
receptor in endotel vascular cells. The binding of
endostatinwith KDR/FlklAIEGFR2 therefore will
cause an increase in free VEGF that is then unable to
function. The process of vasculogenesis and
angiogenesis will be inhibited resulting in lack of blood
vessels formalion and blood flo*..9'20
Differcnce in Average Endostatin Levels Between
LOPE and Normal Pregnancy
The average value of endostatin for LOPE
patients was 86,2n9lml compared to 78,3n9/ml for
normal pregnancies, a difierence of 7,9 (95%
Confidence interval range 5,38-21,10) The value of
p=0,237 (p>0,05) indicating that this difference is not
statistically significant.
This lack of measurable difference could be a
result of several factors that influence the funclion of
endostatin like the groMh factor that stimulates the
proliferation of cells ( fibroblast A FGF2 or VEGF for
. .21
exampre).
This result differs from the findings of
Mahmoudand Abdel Raouf (2006) who discovered
significantly higher levels of endostatin and VEGF in
PE patients compared to women with normal
\r
pregnancies or women who were not pregnant. The
level of endostatin in patients with severe
preeclampsia was higher lhan those withmild pE
inegadless of time of onset.
Endostatin binds to several membrane proteins,
such asfibronectin o5B1 receptor, and interacls with
integrin o5B5 dan ovB3. Endostatin also inhibits the
binding sites endothelialcells and collagen type 1 (
interstitial collaqen ).9
LOPE is influenced by extrinsic or maternal
factors where specific conditions that increase the
mass of the placenta such as diabeties or twins, or
increases the suface area of the plecenta like hypoxia
from the mother or anemla wlll cause an excess of
release of sync'titial knofs. Pregnant women with high
maternal risk factors or inflamation reactions that are
not in line with release of fragments of apoptosis
trophoblastcause the inability of the maternal system
to overcome the rise in apoptosis fragment numbers.
Synctitial knots occur at 32 weeks. These two things
in the end cause secondary necrosis in the blood that
can trigger the clinical symploms ot tOpe.19
As this study was concerned with factors
influencing the role of endostatin other than those
related lo the extrinsic or matemal factors discussed
above, these women (anemia, diabetes, twins) were
excluded from our sample. Hence the results from this
study would not be expected to show the difference in
average endostatin levels between LOPE and nonnal
pregnancy observed in studies that included such
patients.
Difference in average Endostatin levels between
EOPE and LOPE
The average endostatin level in EOPE was
125,09n9/ml compared to86,2ng/ml in LOPE; a
difference of 38,9n9/ml (95% Confidence lnterval
14.17-63.68). The result of the unpaired t test being
p=0,003 (p<0,05) indicating that difference was
statistically signifi cant.
EOPE patients, but not LOPE patients, have
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elevated endostatin levels compared to women with
normal preganacies. Endostatin is an antagonis faclor
for angiogenesis that has a wide ranging influence on
the inhibition of the angiogenesis process that has
not been widely studied.l9
The evidence suggests an imbalance between
placenta angiogenic and antiangiogenic factors exists
with PE that can endanger the vascular endotel and
give rise to clinical symptoms in the mother. The rise
in endostatin levels that occurs in the first trimester is
related to the risk of developing PE.13 lmbalance in
the production of VEGF and endostatin is related to a
number of conditions including systemic sclerosis,
atherosclerosis as well as PEas it influences the cell
proliferation, migration and apoptosis processes
hence influencing morphogenesis dan maturation of
blood vessels.lo
Studies on mice reveal that there is a
pathological change in the placenta with EOPE which
has a detrimental effect on the fetus and its
development that does not appear to occur in
LOPE.33 Hence it has been concluded that wfiile
EOPE is related perfusion of the uteroplacenta, LOPE
is more often related to extrinsic factors like the larger
size of the placenta or some systemic disease in the
.. 25
motner.
Experimental studies have indicated that there is
a positivecorrelation between endostatin levels and
proteinuria value (p=0,663)in patients with chronic
kidney disease. Endostatin is related toduration of
hypertension and vascular index, myocardium and
organdamage that targets the kidneys." This is
explained by the increasein circulation of the level
endostatin increasing extracellularremodeling of the
vascular network.2TEndostatin will inhibit the
functioning of VEGF-A, a factor in thedevelopment of
the kidneys. VEGF-A protects the glomerulus
capillarystruc{ure and the endotel cell and the
peritubular capillary damagerepair processes so
| ilueen Etizaheth ll Conference C*nlreC=il@ E--
inhibiting its function results in impaired renalfunction
increasing the permiability of the basalis
membranecausing leakage and subsequent
proteinuria.2s
EOPE subjects in this study had an average
blood pressure of 1671111 mmHg compared to
1741113 mmHg in the LOPE group. lt has previously
been suggested that endostatin levels could be a
marker for damage and remodeling of the extracellular
matrix in a number of diseases. Long term
hyperlension induces remodeling of the
cardiovascular extracellular matrix. ln hypertension
there is an induction of extracellular remodeling with
the activation of metalloproteinase-2 and
metalloproteinase-9 both of which play an important
role in the degradation of collagen Xvlll to
endostatin.26
There was no difference in Hb levels observed
between the groups in this study except there were
some extreme values of Hb levels in
EOPE.Phalapropkan (2008) concludes that women
with high levels of Hb are at risk of developing of PE
also. Hence it is thought that there are nother risk
factors that influences Hb levels such as palterns of
iron levels in the diet, iron supplements or levels of
fenitin that have not yet been studied.
ln the EOPE group the highest luekocyte count
measured (21,800 m3;and endostatin level 200 ng.
One member of the LOPE group, produced a sample
with the luekocyte count (24,700 ,3) ,nd endostatin
level84,3 ng.
Hypoxia in preeclampsia can aclivate leukocytes
directly in intervillous space or can stimulate the
production oflipoperoxideand proinflammatory
cytokines by the placenta, which can in turn activate
leukocytes as they move through the placental
circulatiory system. lnPE patients there occurs a
modulation of neutrophil which increases the
superoxide anion production to levels above NO
which can cause endothelial damage .
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The inflammation processes involving leukocytes
requires the function of adhesion molecules; the most
important of these in the recruitment of leukocytes are
selectins, integrins of the immunoglobulin superfamily.
Selectin is a single transmembranepolipeptide
expressed in the circulatory cells; endothelium and
blood cells. These molecules are avtivated after
induction. Three types of selectin molecules are
involved; L - selectin in leukocytes , E - selec{in and P
- selec{in in the endothelial cells , these later
particularly in platelets Early PMN adhesion is
mediated by E seleclin that is required for the
antiangiogenic activity of endostatin.30
lntegrin, a transmembrane adhesion molecule is
widely distributed in many cells. Endostatin binds to
integrin ov on the surface of endothelial cells and
influences the process of adhesion of leukocytes and
inhibits the process of angiogenesis.Endostatin
binding to inteqinso an incrcase of endostatinis
associated with funclions by increase in number of
leukocytes in the prcess of leukocyte adhesion and
mediated by integin.lT
The limits of this study is only to observe the
average levels of endostatin as aantiangiogenic faclor,
hence it is not possible to judge the importance of the
imbalance of the VEGF receptor, FAK or other
angiogenic factors related to metabolism or function of
endostatin in endotel cells. The bonding of endostatin
with intergrin or selectin, both important markers in the
adhesion process of leukorytes were not studied
either.
Conclusion
The results of this study show that lhe average
level of endostatin in PE is higher than in normal
pregnanry. The average value of endostatin in EOPE
is higher than in LOPE.
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